Short-Term Risk of Cardiovascular Events in People Newly Diagnosed With Gout

被引:5
|
作者
Cipolletta, Edoardo [1 ,2 ]
Nakafero, Georgina [1 ]
Richette, Pascal [3 ]
Avery, Anthony J. [1 ]
Mamas, Mamas A. [4 ]
Tata, Laila J. [1 ]
Abhishek, Abhishek [1 ]
机构
[1] Univ Nottingham, Nottingham, England
[2] Polytech Univ Marche, Ancona, Italy
[3] Hosp Lariboisiere, INSERM U1132, Paris, France
[4] KEELE UNIV, KEELE, England
关键词
CLINICAL-PRACTICE; RHEUMATOLOGY GUIDELINE; AMERICAN-COLLEGE; MANAGEMENT; DISEASE; INFLAMMATION; ASSOCIATION; SOCIETY; COHORT; FLARES;
D O I
10.1002/art.42986
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTo investigate the temporal association between the first diagnosis of gout and cardiovascular events in the short term.MethodsWe performed a self-controlled case series analysis and a cohort study using data from linked primary care, hospitalization, and mortality records from the United Kingdom's Clinical Practice Research Database-GOLD. We included individuals with a new diagnosis of gout either in the primary care or secondary care between January 1, 1997 and December 31, 2020. The first consultation at which gout was diagnosed was the exposure of interest. The main outcome consisted of cardiovascular events (ie, a composite of fatal and nonfatal myocardial infarction, ischemic or hemorrhagic stroke, and transient ischemic attack).ResultsThe 4,398 patients (66.9% male, mean age 74.6 years) had a cardiovascular event within at least two years of their first recorded diagnosis of gout. The incidence of cardiovascular events was significantly higher in the 30 days after the first diagnosis of gout compared to baseline (adjusted incidence rate ratio 1.55, 95% confidence interval [CI] 1.33-1.83). Among 76,440 patients (72.9% male, mean age 63.2 years) included in the cohort study, the incidence of cardiovascular events in the 30 days after the first gout diagnosis (31.2 events per 1,000 person-years, 95% CI 27.1-35.9) was significantly higher than in days 31 to 730 after gout diagnosis (21.6 events per 1,000 person-years, 95% CI 20.8-22.4) with a rate difference of -9.6 events per 1,000 person-years (95% CI -14.0 to -5.1).ConclusionIndividuals had a short-term increased risk of cardiovascular events in the 30 days following the first consultation at which gout was diagnosed.
引用
收藏
页码:202 / 211
页数:10
相关论文
共 50 条
  • [1] Short-Term Risk of Cardiovascular Events in People Newly Diagnosed With Gout: Comment on the Article by Cipolletta et al
    Liu, Zichang
    Zhu, Yanwei
    Zhao, Hui
    ARTHRITIS & RHEUMATOLOGY, 2025,
  • [2] Short-Term Risk of Cardiovascular Events in People Newly Diagnosed With Gout: Comment on the Article by Cipolletta et al Reply
    Lee, Wayne Y. W.
    Wong, Rongliang
    ARTHRITIS & RHEUMATOLOGY, 2025,
  • [3] Short-Term Change in eGFR and Risk of Cardiovascular Events
    Turin, Tanvir Chowdhury
    James, Matthew T.
    Jun, Min
    Tonelli, Marcello
    Coresh, Joseph
    Manns, Braden J.
    Hemmelgarn, Brenda R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (05):
  • [4] Short-term use of rofecoxib increases the risk for adverse cardiovascular events
    Nature Clinical Practice Oncology, 2007, 4 : 621 - 621
  • [5] Short-term use of rofecoxib increases the risk for adverse cardiovascular events
    不详
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (11): : 621 - 621
  • [6] Temporal changes in risk of cardiovascular events in people with newly diagnosed type 2 diabetes with and without cardiovascular disease
    Norgaard, Caroline H.
    Starkopf, Liis
    Gerds, Thomas A.
    Malmborg, Morten
    Bonde, Anders N.
    Zareini, Bochra
    Mills, Elisabeth Helen Anna
    Vestergaard, Peter
    Wong, Nathan D.
    Torp-Pedersen, Christian
    Lee, Christina J-Y
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (02)
  • [7] Methylphenidate and Short-Term Cardiovascular Risk
    Garcia-Argibay, Miguel
    Buerkner, Paul-Christian
    Lichtenstein, Paul
    Zhang, Le
    D'Onofrio, Brian M.
    Andell, Pontus
    Chang, Zheng
    Cortese, Samuele
    Larsson, Henrik
    JAMA NETWORK OPEN, 2024, 7 (03) : E241349
  • [8] Sepsis, cardiovascular events and short-term mortality risk in critically ill patients
    Ho, Sharlene
    Phua, Hwee Pin
    Lim, Wei-Yen
    Mahalingam, Niranjana
    Tan, Guan Hao Chester
    Puah, Ser Hon
    Lew, Jin Wen Sennen
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2022, 51 (05) : 272 - 282
  • [9] A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events
    Andrea Cappozzo
    Cathal McCrory
    Oliver Robinson
    Anna Freni Sterrantino
    Carlotta Sacerdote
    Vittorio Krogh
    Salvatore Panico
    Rosario Tumino
    Licia Iacoviello
    Fulvio Ricceri
    Sabina Sieri
    Paolo Chiodini
    Gareth J. McKay
    Amy Jayne McKnight
    Frank Kee
    Ian S. Young
    Bernadette McGuinness
    Eileen M. Crimmins
    Thalida Em Arpawong
    Rose Anne Kenny
    Aisling O’Halloran
    Silvia Polidoro
    Giuliana Solinas
    Paolo Vineis
    Francesca Ieva
    Giovanni Fiorito
    Clinical Epigenetics, 2022, 14
  • [10] A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events
    Cappozzo, Andrea
    McCrory, Cathal
    Robinson, Oliver
    Sterrantino, Anna Freni
    Sacerdote, Carlotta
    Krogh, Vittorio
    Panico, Salvatore
    Tumino, Rosario
    Iacoviello, Licia
    Ricceri, Fulvio
    Sieri, Sabina
    Chiodini, Paolo
    McKay, Gareth J.
    McKnight, Amy Jayne
    Kee, Frank
    Young, Ian S.
    McGuinness, Bernadette
    Crimmins, Eileen M.
    Arpawong, Thalida Em
    Kenny, Rose Anne
    O'Halloran, Aisling
    Polidoro, Silvia
    Solinas, Giuliana
    Vineis, Paolo
    Ieva, Francesca
    Fiorito, Giovanni
    CLINICAL EPIGENETICS, 2022, 14 (01)